Medication

GRÄFELFING, Germany, June 9, 2026 /PRNewswire/ — VERTANICAL today announced that Exilby® (VER-01) has received marketing authorization in…

Children’s paracetamol remain in low supply. Photo: RNZ / Samuel Rillstone Samoa’s national hospital is rationing critical medicine…

Novo Nordisk NVO remains one of the dominant players in the rapidly expanding obesity treatment market. The company markets…

Image By: Dr. Iilun Murphy, Director Office of Generic Drugs, Center for Drug Evaluation and Research (CDER) and…

Kelsey Davis/The Globe and Mail We’re living in the age of supplements. Within the wellness space, the global…

A drug that promotes muscle growth could significantly reduce the loss of lean body mass when using slimming…

When temperatures climb to 105º in Arizona, most people know the importance of drinking water, finding shade, and…

Photo: RNZ / Samuel Rillstone A drug used to slow some types of cancer and treat endometriosis symptoms…

Canadian-led team of scientists discover new antibiotic hidden in decades-old bacterium CTV NewsA natural depsipeptide antibiotic binds the E-site…

Photo: RNZ / Samuel Rillstone A drug used to slow some types of cancer and treat endometriosis symptoms…

Mayim Bialik is speaking out candidly about a severe reaction she says she experienced after taking a GLP-1…

In ATTAIN-1, women in perimenopause taking Foundayo lost up to 30.4 lbs (14.4%) and those in post-menopause lost up to 28.2 lbs (14.1%)…

VERTANICAL Receives First European Marketing Authorization for Exilby® as a First-in-Class Non-Opioid Treatment for Chronic Low Back Pain